Predicting rapid radiographic progression in difficult-to-treat rheumatoid arthritis: insights from long-term follow-up
Open Access
- 1 October 2025
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (1)
Abstract
Objectives: To investigate the long-term trajectory of radiographic progression in difficult-to-treat rheumatoid arthritis (D2T RA) and poly-refractory RA (pr-RA) patients and to evaluate the impact of ultrasound-based persistent inflammatory refractory RA (PIRRA) and non-inflammatory refractory RA (NIRRA) classification on predicting rapid radiographic progression (RRP, ≥5 mSvdH units/year). Methods: Radiographic damage was assessed using the modified Sharp/van der Heijde (mSvdH) score in EULAR-defined D2T RA patients. PIRRA and NIRRA subgroups were classified based on a single ultrasound time point assessing grayscale and power Doppler synovitis. The impact of time-integrated CRP and swollen joint counts (SJC) on radiographic progression was examined. Results: Among 254 D2T RA patients, 114 had serial radiographs with a mean follow-up of 9 years. The mean annual mSvdH progression was 2.8 units with both time-integrated CRP (P < 0.001) and the PIRRA patients (n = 43) having significantly greater annual radiographic progression (3.3 units in PIRRA vs 2.4 units in NIRRA, P = 0.025). In multivariable analysis, older age (P = 0.017) and swollen joint count (P = 0.009) were independently associated with RRP. Additionally, RRP was observed in 50% of pr-RA patients (n = 14) vs 19.4% in other D2T RA cases (P = 0.048). Conclusion: Although pr-RA cases are an uncommon subgroup, half of them demonstrated RRP, emphasizing the need for more aggressive treatment approaches. In contrast, many D2T RA patients exhibited comparatively slow radiographic progression indicating that many D2T RA cases are at least partially treated. These findings underscore the heterogeneity within D2T RA and highlight the need for additional strategies for the pr-RA subgroup.Keywords
This publication has 34 references indexed in Scilit:
- Diagnosis and Management of Rheumatoid ArthritisJAMA, 2018
- Performance of Matrix‐Based Risk Models for Rapid Radiographic Progression in a Cohort of Patients With Established Rheumatoid ArthritisArthritis Care & Research, 2012
- Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structuArthritis & Rheumatism, 2011
- The effects of golimumab on radiographic progression in rheumatoid arthritis: Results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapyArthritis & Rheumatism, 2011
- Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trialArthritis & Rheumatism, 2006
- Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trialArthritis & Rheumatism, 2005
- Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy studyArthritis & Rheumatism, 2005
- The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritisArthritis & Rheumatism, 2001
- The course of radiologic damage during the first six years of rheumatoid arthritisArthritis & Rheumatism, 2000
- Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritisArthritis & Rheumatism, 2000